Bipolar Androgen Therapy for Prostate Cancer
Phase 1
14
about 3 years
18+
Male only
1 site in NY
What this study is about
This trial is testing a new treatment called bipolar androgen therapy, which involves regulating testosterone levels in men with advanced prostate cancer that has spread. The goal of this treatment is to see if it can change how sensitive the cancer cells are to hormone therapies and improve side effects.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Survey Administration
- 2.Take Leuprolide Acetate
- 3.Take Testosterone Cypionate
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Antineoplastic Agent [TC] (Gonadotropin Releasing Hormone Receptor Agonists), Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Androgen Receptor Agonists)
injection, intramuscular
Secondary: Assess Fatigue, Assess Quality of Life, Assess change in Fatigue, Incidence of adverse events, Incidence of serious adverse events, Overall survival, Progression free survival
biopsy, imaging
Oncology